VEVEY, Switzerland, March 27, 2013 /PRNewswire/ -- Cancer patients referred to Hopital Riviera's (Vevey, Switzerland) new radiotherapy clinic will soon benefit from the center's acquisition of Elekta's advanced new linear accelerator, Versa HD™. The system, currently being installed, will be the centerpiece of Hopital Riviera's modern radiotherapy department, which is scheduled to begin patient treatments in June. Hopital Riviera will maintain its collaborative clinical operations with Centre Hospitalier Universitaire Vaudois (CHUV, Lausanne).
Versa HD, unveiled by Elekta on March 1, is designed to be the most sophisticated, high-versatility treatment system, giving clinicians the flexibility to deliver conventional therapies to treat a wide range of small and large tumors throughout the body, while also enabling treatment of highly complex cancers that require extreme targeting precision. Treatment of the most challenging cases is facilitated by high-definition beam shaping, in addition to a groundbreaking high dose rate delivery mode.
"High-definition, high-speed beam shaping combined with high dose rate delivery makes Versa HD the ideal SBRT machine," says Oscar Matzinger , M.D., radiation oncologist at Hopital Riviera and CHUV. "Still, Versa HD will be our mainstay for basic and palliative treatments and support our future expansion of radiotherapy capabilities."
The first-ever combination of high-precision beam shaping plus high dose rate delivery in Versa HD will significantly improve the execution of SBRT (stereotactic body radiation therapy), Dr. Matzinger adds.
"An increasing share of radiation oncology patients in the future will be treated with SBRT, which historically has entailed relatively long treatment times," he says. "If we are talking about treating lung cancer or liver metastases, the faster we can deliver therapy the les
Copyright©2012 PR Newswire.
All rights reserved